Latest IBD Stories
OAKLAND, Calif., Nov. 30, 2010 /PRNewswire-USNewswire/ -- The Kenneth Rainin Foundation announced today its 2011 Innovator Awards Program for Inflammatory Bowel Disease. The Program, now in its second year, is designed to accelerate the pace of discovery in IBD research.
MOUNTAIN VIEW, Calif., Oct.
At the American College of Gastroenterologyâ€™s (ACG) 75th Annual Scientific meeting in San Antonio, Texas, several studies of the effectiveness of nonâ€Xâ€ray techniques to evaluate Crohnâ€™s disease revealed that diagnostic strategies such as capsule endoscopy (CE) and magnetic resonance enteroscopy (MRE) are useful in managing patients with inflammatory bowel disease (IBD) and avoiding ionizing radiation.
Vitamin D deficiency puts patients with Inflammatory Bowel Disease (IBD) at greater risk of osteoporosis, osteopenia and an overall higher rate of abnormal bone density.
The association between obesity and gastrointestinal-related cancers and coronary artery disease; the link between an overweight or obese body mass index and the severity of Crohn's disease; and whether inflammatory bowel disease is an independent risk factor for coronary artery disease, were among the highlights of new research that was presented this week at the American College of Gastroenterology's (ACG) 75th Annual Scientific meeting in San Antonio.
UPPER SADDLE RIVER, N.J., Sept. 27 /PRNewswire/ -- WellApps, LLC announced today that it has expanded GI Monitor, its successful (IBD) Crohn's and Colitis symptom tracking application, to Android phones in response to patient demand.
Certain bacteria that inhabit the intestine provide the environmental trigger that initiates and perpetuates chronic intestinal inflammation in individuals who are genetically susceptible to inflammatory bowel disease (IBD).
BOULDER, Colo., Sept. 8 /PRNewswire/ -- N30 Pharmaceuticals, LLC today announced it has dosed the first human subject with N6022, a first-in-class inhibitor of s-nitrosoglutathione reductase (GSNOR). N6022 is the first GSNOR inhibitor to be administered to human beings.
OAKLAND, Calif., Aug. 4 /PRNewswire-USNewswire/ -- The Kenneth Rainin Foundation announced today the recipients of its 2010 Innovator Awards Program for Inflammatory Bowel Disease (IBD).
BOULDER, Colo., Aug. 2 /PRNewswire/ -- N30 Pharmaceuticals, LLC today announced the approval of its Investigational New Drug Application for N6022 by the U.S. Food and Drug Administration.
- a meat pie that is usually eaten at Christmas in Quebec